NCBS - ニコレット・バンクシェア―ズ (Nicolet Bankshares Inc.) ニコレット・バンクシェア―ズ

 NCBSのチャート


 NCBSの企業情報

symbol NCBS
会社名 Nicolet Bankshares Inc (ニコレット・バンクシェア―ズ)
分野(sector) Finance   金融
産業(industry) Major Banks  
業種 銀行   金融(Financials)
概要 事業概要 ニコレット・バンクシェアズ(Nicolet Bankshares Inc.)は銀行持株会社である。同社はNicolet National Bank(同行)という商業銀行子会社を通じて事業を展開する。同社はまた、地域の銀行を選択するための投資戦略と取引サービスを提供する投資顧問会社のBrookfield Investment Partners LLC、および主に個人消費者に仲介および財務アドバイザリー・サービスを提供する投資顧問会社のNicolet Advisory Services LLCを所有する。同行は、従来型の銀行商品・サービス、および資産管理商品およびサービスを企業および個人に提供するサービスコミュニティ銀行である。同社の主要事業は、貸出および預金の収集、地域社会の企業と個人向けの補助的な銀行関連の商品とサービス、及び銀行商品およびサービスの提供、資金調達および管理のための運用サポートを含む銀行業務である。   ニコレット・バンクシェア―ズは米国の銀行持株会社。子会社ニコレット・ナショナル・バンクを通じ、ウィスコンシン州内の10郡で企業や個人向けに銀行業務に従事する。オンラインやモバイル・バンキングを提供し、通常の銀行サ―ビスに加え資産管理・運用サ―ビスも展開する。また、投資顧問会社を所有する。本社はウィスコンシン州グリ―ンベイ。   Nicolet Bankshares, Inc. is a holding company, which engages in the provision of commercial and consumer banking services through its subsidiary. It offers lending and deposit gathering, ancillary banking-related, trust, brokerage, and other investment management products and services. The firm also delivers commercial-related and residential real estate loans. The company was founded by Robert Bruc Atwell and Michael E. Daniels on April 5, 2000 and is headquartered in Green Bay, WI.
本社所在地 111 North Washington Street Green Bay WI 54301 USA
代表者氏名 Robert B. Atwell ロバート・B・アトウェル
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 920-430-1400
設立年月日 36617
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 535人
url www.nicoletbank.com
nasdaq_url https://www.nasdaq.com/symbol/ncbs
adr_tso
EBITDA EBITDA(百万ドル) 64.75800
終値(lastsale) 54.31
時価総額(marketcap) 523807675.94
時価総額 時価総額(百万ドル) 507.60450
売上高 売上高(百万ドル) 120.62000
企業価値(EV) 企業価値(EV)(百万ドル) 485.48450
当期純利益 当期純利益(百万ドル) 38.81400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Nicolet Bankshares Inc interest income increased 23% to $61.3M. Net interest income after loan loss provision increased 15% to $51.7M. Net income increased 33% to $19.3M. Net interest income after loan loss provision reflects Loans including Loan Fees increase of 22% to $55.6M Other interest income increase from $730K to $1.6M. Net income benefited from Brokerage Fee Income increase of 24% to $3.3M (income).

 NCBSのテクニカル分析


 NCBSのニュース

   Nicolet Bankshares Inc (NASDAQ:NCBS) EVP Sells $139,393.31 in Stock  2020/10/23 16:52:45 US Banking News
Nicolet Bankshares Inc (NASDAQ:NCBS) EVP Eric James Witczak sold 2,177 shares of the firm’s stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $64.03, for a total transaction of $139,393.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which […]
   Nicolet Bankshares (NASDAQ:NCBS) Issues Quarterly Earnings Results, Beats Estimates By $0.32 EPS  2020/10/21 09:15:20 Stock Observer
Nicolet Bankshares (NASDAQ:NCBS) issued its quarterly earnings data on Tuesday. The bank reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.32, MarketWatch Earnings reports. Nicolet Bankshares had a return on equity of 10.02% and a net margin of 25.25%. NCBS stock opened at $60.47 on Wednesday. The stock […]
   Nicolet Bankshares, Inc. Announces First Quarter 2020 Earnings  2020/04/21 20:05:00 PR Newswire
GREEN BAY, Wis., April 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced first quarter 2020 net income of $10.6 million and earnings per diluted common share of $0.98, compared to $12.3 million and $1.18 for fourth quarter 2019, and $10.3 million and…
   Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon  2020/02/03 22:25:00 Zero Hedge
Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Via GreatGameIndia.com, In an explosive interview Dr. Francis Boyle, who drafted the Biological Weapons Act has given a detailed statement admitting that the 2019 Wuhan Coronavirus is an offensive Biological Warfare Weapon and that the World Health Organization (WHO) already knows about it. Dr. Francis Boyle Creator Of BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Francis Boyle is a professor of international law at the University of Illinois College of Law. He drafted the U.S. domestic implementing legislation for the Biological Weapons Convention, known as the Biological Weapons Anti-Terrorism Act of 1989, that was approved unanimously by both Houses of the U.S. Congress and signed into law by President George H.W. Bush. In an exclusive interview given to Geopolitics and Empire , Dr. Boyle discusses the coronavirus outbreak in Wuhan, China and the Biosafety Level 4 laboratory (BSL-4) from which he believes the infectious disease escaped.
   Bankshares, Inc. Announces Record 2019 Earnings  2020/01/21 21:05:00 PR Newswire
GREEN BAY, Wis., Jan. 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced fourth quarter 2019 net income of $12.3 million and earnings per diluted common share of $1.18, compared to $13.5 million and $1.40 for third quarter 2019, and $10.9 million and $1….
   Nicolet Bankshares, Inc. Announces First Quarter 2020 Earnings  2020/04/21 20:05:00 PR Newswire
GREEN BAY, Wis., April 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced first quarter 2020 net income of $10.6 million and earnings per diluted common share of $0.98, compared to $12.3 million and $1.18 for fourth quarter 2019, and $10.3 million and…
   Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon  2020/02/03 22:25:00 Zero Hedge
Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Via GreatGameIndia.com, In an explosive interview Dr. Francis Boyle, who drafted the Biological Weapons Act has given a detailed statement admitting that the 2019 Wuhan Coronavirus is an offensive Biological Warfare Weapon and that the World Health Organization (WHO) already knows about it. Dr. Francis Boyle Creator Of BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Francis Boyle is a professor of international law at the University of Illinois College of Law. He drafted the U.S. domestic implementing legislation for the Biological Weapons Convention, known as the Biological Weapons Anti-Terrorism Act of 1989, that was approved unanimously by both Houses of the U.S. Congress and signed into law by President George H.W. Bush. In an exclusive interview given to Geopolitics and Empire , Dr. Boyle discusses the coronavirus outbreak in Wuhan, China and the Biosafety Level 4 laboratory (BSL-4) from which he believes the infectious disease escaped.
   Bankshares, Inc. Announces Record 2019 Earnings  2020/01/21 21:05:00 PR Newswire
GREEN BAY, Wis., Jan. 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced fourth quarter 2019 net income of $12.3 million and earnings per diluted common share of $1.18, compared to $13.5 million and $1.40 for third quarter 2019, and $10.9 million and $1….
   Nicolet Bankshares (NCBS) Hits 52-Week High, Can the Run Continue?  2019/07/18 13:15:10 Zacks Investment Research
Nicolet Bankshares (NCBS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
   Nicolet Bankshares (NCBS) Beats Q2 Earnings and Revenue Estimates  2019/07/16 21:45:04 Zacks Investment Research
Nicolet Bankshares (NCBS) delivered earnings and revenue surprises of 21.43% and 25.34%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
   Nicolet Bankshares, Inc. Announces First Quarter 2020 Earnings  2020/04/21 20:05:00 PR Newswire
GREEN BAY, Wis., April 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced first quarter 2020 net income of $10.6 million and earnings per diluted common share of $0.98, compared to $12.3 million and $1.18 for fourth quarter 2019, and $10.3 million and…
   Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon  2020/02/03 22:25:00 Zero Hedge
Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Via GreatGameIndia.com, In an explosive interview Dr. Francis Boyle, who drafted the Biological Weapons Act has given a detailed statement admitting that the 2019 Wuhan Coronavirus is an offensive Biological Warfare Weapon and that the World Health Organization (WHO) already knows about it. Dr. Francis Boyle Creator Of BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Francis Boyle is a professor of international law at the University of Illinois College of Law. He drafted the U.S. domestic implementing legislation for the Biological Weapons Convention, known as the Biological Weapons Anti-Terrorism Act of 1989, that was approved unanimously by both Houses of the U.S. Congress and signed into law by President George H.W. Bush. In an exclusive interview given to Geopolitics and Empire , Dr. Boyle discusses the coronavirus outbreak in Wuhan, China and the Biosafety Level 4 laboratory (BSL-4) from which he believes the infectious disease escaped.
   Bankshares, Inc. Announces Record 2019 Earnings  2020/01/21 21:05:00 PR Newswire
GREEN BAY, Wis., Jan. 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced fourth quarter 2019 net income of $12.3 million and earnings per diluted common share of $1.18, compared to $13.5 million and $1.40 for third quarter 2019, and $10.9 million and $1….
   Nicolet Bankshares (NCBS) Hits 52-Week High, Can the Run Continue?  2019/07/18 13:15:10 Zacks Investment Research
Nicolet Bankshares (NCBS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
   Nicolet Bankshares (NCBS) Beats Q2 Earnings and Revenue Estimates  2019/07/16 21:45:04 Zacks Investment Research
Nicolet Bankshares (NCBS) delivered earnings and revenue surprises of 21.43% and 25.34%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

 関連キーワード  (銀行 米国株 ニコレット・バンクシェア―ズ NCBS Nicolet Bankshares Inc.)

個人や企業から預金を集めて、それを企業や個人に融資をする金融機関。営業基盤が全国規模の都市銀行、営業基盤が一地方に限定された地方銀行、顧客の財産管理の代行が主要業務である信託銀行などがある。

 twitter  (公式ツイッターやCEOツイッターなど)